SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-155866
Filing Date
2020-05-29
Accepted
2020-05-29 16:35:07
Documents
16
Period of Report
2020-05-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d886292d8k.htm   iXBRL 8-K 44088
2 EX-99.1 d886292dex991.htm EX-99.1 1211897
3 EX-99.2 d886292dex992.htm EX-99.2 821578
7 GRAPHIC g886292g24v99.jpg GRAPHIC 4722
8 GRAPHIC g886292g98i44.jpg GRAPHIC 8550
  Complete submission text file 0001193125-20-155866.txt   2455325

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ck0001792044-20200529.xsd EX-101.SCH 2774
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001792044-20200529_lab.xml EX-101.LAB 15301
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001792044-20200529_pre.xml EX-101.PRE 9664
10 EXTRACTED XBRL INSTANCE DOCUMENT d886292d8k_htm.xml XML 3139
Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 (212) 733-2323
Upjohn Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56114 | Film No.: 20928525
SIC: 2834 Pharmaceutical Preparations